Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02125383 · ClinicalTrials.gov registry record · NA
ParkinStim: Transcranial Direct Current Stimulation for Parkinson's Disease
A NA study, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02125383 is a NA study that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 9 participants.
The verdict
NCT02125383, a NA study, has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of transcranial direct current stimulation (tDCS) on patients with Parkinson's disease during sleep.
Interventions
- PROCEDURE Sham tDCS
- PROCEDURE Active tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02125383
The ClinicalTrials.gov registry entry for NCT02125383 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Great Lakes NeuroTechnologies, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham tDCS is the first listed.
NCT02125383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02125383 about?
NCT02125383 is a clinical study titled "ParkinStim: Transcranial Direct Current Stimulation for Parkinson's Disease". The purpose of this study is to evaluate the effects of transcranial direct current stimulation (tDCS) on patients with Parkinson's disease during sleep.
What is the current status of trial NCT02125383?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2014-04. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02125383?
The interventions under investigation include: Sham tDCS (PROCEDURE), Active tDCS (PROCEDURE).
Who is sponsoring clinical trial NCT02125383?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.